These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26796520)

  • 1. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
    Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
    Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
    Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.
    Shen Z; Cao B; Lin L; Zhou C; Ye D; Qiu S; Li Q; Cui X
    Med Sci Monit; 2017 Jul; 23():3635-3640. PubMed ID: 28743857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
    World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma.
    Shen Z; Hu Y; Zhou C; Yuan J; Xu J; Hao W; Deng H; Ye D
    J Clin Lab Anal; 2019 Jul; 33(6):e22899. PubMed ID: 31002184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
    Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
    Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of RUNX3 Methylation with Clinical Outcome and Cell Migration/Invasion in Laryngeal Squamous Cell Carcinoma.
    Liu ZH; Liu JJ; Li SS; Yang XM
    Cancer Invest; 2016; 34(2):105-13. PubMed ID: 26853927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.
    Shen Z; Chen X; Li Q; Zhou C; Xu Y; Yu R; Ye H; Li J; Duan S
    Clin Biochem; 2016 Nov; 49(16-17):1278-1282. PubMed ID: 27521994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
    Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
    Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
    Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
    Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
    Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
    Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
    Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.